Approved indication: Tizanidine is approved for the management of spasticity, such as muscle tightness and spasms that can occur with conditions like multiple sclerosis or spinal cord injury.

Off-label uses (evidence level generally limited or mixed):

• Musculoskeletal conditions with painful muscle spasms (for example, chronic neck or low-back pain).
• Certain chronic headache conditions (such as chronic tension-type headache or migraine prevention) when other options are inadequate.
• Other neuropathic or central pain syndromes in selected patients under specialist supervision.

Efficacy expectations: Relaxation of muscle tone and reduction in spasm frequency typically begin within about 1–2 hours after a dose and last around 3–6 hours; many patients notice symptom relief at relatively low doses, but benefits must be balanced against drowsiness and low blood pressure. In comparative use, tizanidine is generally as effective as other oral antispastic agents (such as baclofen) for reducing tone, but it is shorter-acting and often more limited by sedation and hypotension, so it is commonly used when a short, targeted effect is desired.

Typical adult dosing: For spasticity, tizanidine is usually started at 2–4 mg by mouth up to three times daily (every 6–8 hours as needed), then increased slowly by 2–4 mg at intervals of several days until muscle tone is adequately reduced, not exceeding 36 mg in 24 hours or more than three doses in a day.

How to take it: Tizanidine tablets and capsules may be taken with or without food, but you should take them the same way every time because food changes how much drug is absorbed. Capsules and tablets are not interchangeable on a milligram-for-milligram basis when taken with or without food, so any change in formulation or timing with meals should be directed by a clinician. Swallow tablets or capsules whole (or follow pharmacist instructions if the capsule contents are mixed with soft food).

Special dosing instructions: In older adults or people with kidney problems, clinicians typically use lower starting doses and slower increases. In significant liver disease, tizanidine is often avoided, or if used, it is at low doses with careful monitoring. When stopping after higher or long-term doses, the dose should be tapered down gradually (for example, by 2–4 mg per day) to reduce the risk of rebound high blood pressure, fast heartbeat, or worsening spasticity.

Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; if it is close to the next scheduled dose, skip the missed dose and resume your regular schedule, and do not double up to make up for a missed dose.

Overdose: Taking too much tizanidine can cause extreme drowsiness, confusion, very low blood pressure, slow heart rate, or breathing problems; in case of suspected overdose, call emergency services or a poison control center immediately, and do not try to drive yourself to medical care.

Common side effects: The most frequent effects include drowsiness, dizziness, dry mouth, weakness or fatigue, and sometimes low blood pressure or slow heart rate; these usually appear soon after dosing, are more likely as the dose increases, and often improve or become more manageable as the dose is adjusted.

Serious or rare adverse effects: Seek urgent medical attention for fainting, chest pain, very slow or irregular heartbeat, confusion, hallucinations, severe dizziness, yellowing of the skin or eyes, dark urine, unexplained nausea or abdominal pain (possible liver injury), or signs of a severe allergic reaction such as trouble breathing, swelling of the face, lips, tongue, or throat, or widespread rash.

Warnings and precautions: Use with caution in people with low blood pressure, heart rhythm problems, or those taking blood pressure medicines, as tizanidine can further lower blood pressure and heart rate. Liver problems have been reported, so it is generally avoided in significant liver disease and may require blood tests to monitor liver function, especially at higher or long-term doses. In kidney impairment, doses are usually reduced and patients monitored closely. It is not approved in children; in older adults, clinicians often start with lower doses because of greater sensitivity to drowsiness and drops in blood pressure. In pregnancy, use is reserved for situations where the potential benefit justifies potential risks; during breastfeeding, data are limited, so prescribers may prefer alternative therapies or close monitoring.

Safety compared with similar drugs: Compared with some other muscle relaxants and antispastic agents, tizanidine commonly causes more sedation and blood pressure lowering but has a relatively short duration of action, which can be useful when brief control of spasticity is needed; abrupt discontinuation after long-term or high-dose use can cause rebound high blood pressure and rapid heart rate, so doses are usually tapered.

Reporting and staying informed: Patients in the United States can report side effects to the FDA through the MedWatch program (online or by phone) and can check FDA drug safety communications for any new warnings or recommendations about tizanidine; pharmacists and prescribers can also provide up-to-date safety information.

Major drug interactions: Tizanidine is broken down mainly by the liver enzyme CYP1A2, so strong inhibitors of this enzyme such as fluvoxamine and ciprofloxacin are contraindicated because they can greatly increase tizanidine levels and cause dangerous drops in blood pressure and excessive sedation. Other CYP1A2 inhibitors (for example, certain antiarrhythmics, zileuton, cimetidine, famotidine, some oral contraceptives, acyclovir, and ticlopidine) can also raise tizanidine levels and should generally be avoided or used only with close monitoring and dose adjustment.

Interactions with other medicines and substances: Alcohol and other medicines that depress the central nervous system (such as benzodiazepines, opioids, sedating antidepressants, or other muscle relaxants) can add to drowsiness and impair thinking or coordination. Blood pressure medicines, especially other alpha-2 agonists or beta-blockers, can enhance tizanidine’s blood pressure–lowering effect and increase the risk of dizziness or fainting. Always check with a pharmacist or prescriber before combining tizanidine with new prescription drugs, over-the-counter medicines, or herbal supplements.

Food, drink, and procedure interactions: Food changes how much tizanidine is absorbed, so it should be taken consistently with respect to meals rather than switching between taking it with food and on an empty stomach. There are no specific known interactions with imaging contrast agents or most diagnostic procedures, but clinicians should be aware of the potential for low blood pressure and sedation around the time of procedures.

Precautions and monitoring: Tizanidine should be used cautiously in people with low baseline blood pressure, heart rhythm problems, liver disease, or significant kidney impairment, and in those taking multiple blood pressure–lowering or sedating medicines. Blood pressure and heart rate are often checked during dose increases, and liver function tests may be done at baseline and periodically, especially at higher or long-term doses, to detect liver injury early.

Q: Is tizanidine a painkiller or a muscle relaxant?
A: Tizanidine is a centrally acting muscle relaxant that reduces muscle spasms and stiffness, which can indirectly lessen pain, but it is not a traditional painkiller like NSAIDs or opioids.

Q: How long does it take for tizanidine to start working and how long does it last?
A: Tizanidine usually starts to relax muscles within about 1–2 hours after a dose, and its effects typically last around 3–6 hours, which is why it may be taken several times a day.

Q: Can I drive or operate machinery while taking tizanidine?
A: Because tizanidine commonly causes drowsiness, dizziness, and slowed reaction time, you should see how it affects you first and avoid driving or operating machinery if you feel sleepy, light-headed, or less alert.

Q: Is it safe to drink alcohol while taking tizanidine?
A: Alcohol can increase tizanidine’s sedative and blood pressure–lowering effects, so combining them can make you very drowsy or dizzy, and most patients are advised to avoid or strictly limit alcohol while using tizanidine.

Q: Can I stop tizanidine suddenly if I feel better?
A: If you have been taking higher doses or using tizanidine regularly for a long time, stopping abruptly can cause rebound high blood pressure, fast heart rate, or worsening spasms, so it is usually tapered slowly under a clinician’s guidance.

Q: What should I do if tizanidine makes me too sleepy?
A: Contact your prescriber; they may reduce your dose, change how often you take it, adjust the timing (for example, using more at night), or consider an alternative medicine to balance symptom relief with side effects.

Storage: Store tizanidine tablets or capsules at room temperature (about 68–77°F or 20–25°C), in a tightly closed original container, away from excess heat, moisture, and direct light, and out of reach of children and pets.

Disposal: If you no longer need the medication or it is expired, use a community drug take-back program when available; if none is accessible, mix the tablets or capsule contents with an undesirable substance (such as coffee grounds or cat litter), seal in a plastic bag or container, and place in household trash, unless your pharmacist or local guidance specifically instructs flushing.